Kishi T, Yoshida T, Terada M
Genetics Division, National Cancer Center Research Institute, Tokyo, Japan.
Biochem Biophys Res Commun. 1994 Aug 15;202(3):1387-94. doi: 10.1006/bbrc.1994.2084.
K-SAM/FGFR2 gene encodes a receptor tyrosine kinase which belongs to the fibroblast growth factor receptor family and is amplified and overexpressed in KATO-III gastric cancer cells. To characterize K-sam proteins in cancer cells, anti-K-sam rabbit polyclonal antibody PK1-2 was raised and used for the immunoprecipitation analysis. 135, 125, and 110-kDa transmembrane proteins were detected in KATO-III cell lysate, while a soluble truncated 85-kDa K-sam protein was found in the conditioned medium. The molecular size of the soluble K-sam protein does not match with those predicted from the secreted forms of the K-sam cDNA which have been cloned so far. The soluble K-sam protein was highly N-glycosylated like the transmembrane versions, and N-glycosylation appeared to be necessary for its release.
K-SAM/FGFR2基因编码一种受体酪氨酸激酶,它属于成纤维细胞生长因子受体家族,在KATO-III胃癌细胞中发生扩增和过表达。为了表征癌细胞中的K-sam蛋白,制备了抗K-sam兔多克隆抗体PK1-2并用于免疫沉淀分析。在KATO-III细胞裂解物中检测到135、125和110 kDa的跨膜蛋白,而在条件培养基中发现了一种可溶性截短的85 kDa K-sam蛋白。可溶性K-sam蛋白的分子大小与目前已克隆的K-sam cDNA分泌形式所预测的大小不匹配。可溶性K-sam蛋白与跨膜形式一样高度N-糖基化,N-糖基化似乎是其释放所必需的。